MedTrace Logo

Immune Benefits of Coffee

NCT00860197 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 116

Last updated 2015-12-02

No results posted yet for this study

Summary

This study will assess whether coffee consumption:

* increases immune responses
* decreases inflammatory status

Conditions

  • Immune Senescence
  • Low-grade Inflammation

Interventions

DIETARY_SUPPLEMENT

Fully torrefied coffee

Fully torrefied coffee

DIETARY_SUPPLEMENT

Partially torrefied coffee

Partially torrefied coffee

Sponsors & Collaborators

  • Société des Produits Nestlé (SPN)

    collaborator INDUSTRY

  • University of Chile

    lead OTHER

Principal Investigators

  • Daniel Bunout, MD · INTA University of Chile, Santiago, Metropolitana, Chile

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2009-05-31
Completion
2010-02-28

Countries

  • Chile

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00860197 on ClinicalTrials.gov